Short-Term Outcomes and Safety of Computed Tomography-Guided Percutaneous Microwave Ablation of Solitary Adrenal Metastasis from Lung Cancer: A Multi-Center Retrospective Study.
10.3348/kjr.2016.17.6.864
- Author:
Min MEN
1
;
Xin YE
;
Weijun FAN
;
Kaixian ZHANG
;
Jingwang BI
;
Xia YANG
;
Aimin ZHENG
;
Guanghui HUANG
;
Zhigang WEI
Author Information
1. Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University, Jinan, Shandong Province 250021, China. yexintaian2014@163.com
- Publication Type:Multicenter Study ; Original Article
- Keywords:
Adrenal;
Microwave ablation;
CT-guided;
Lung cancer;
Metastasis
- MeSH:
Disease-Free Survival;
Ethics Committees, Research;
Follow-Up Studies;
Humans;
Lung Neoplasms*;
Lung*;
Microwaves*;
Neoplasm Metastasis*;
Retrospective Studies*;
Survival Rate
- From:Korean Journal of Radiology
2016;17(6):864-873
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: To retrospectively evaluate the short-term outcomes and safety of computed tomography (CT)-guided percutaneous microwave ablation (MWA) of solitary adrenal metastasis from lung cancer. MATERIALS AND METHODS: From May 2010 to April 2014, 31 patients with unilateral adrenal metastasis from lung cancer who were treated with CT-guided percutaneous MWA were enrolled. This study was conducted with approval from local Institutional Review Board. Clinical outcomes and complications of MWA were assessed. RESULTS: Their tumors ranged from 1.5 to 5.4 cm in diameter. After a median follow-up period of 11.1 months, primary efficacy rate was 90.3% (28/31). Local tumor progression was detected in 7 (22.6%) of 31 cases. Their median overall survival time was 12 months. The 1-year overall survival rate was 44.3%. Median local tumor progression-free survival time was 9 months. Local tumor progression-free survival rate was 77.4%. Of 36 MWA sessions, two (5.6%) had major complications (hypertensive crisis). CONCLUSION: CT-guided percutaneous MWA may be fairly safe and effective for treating solitary adrenal metastasis from lung cancer.
